Synergistic interaction of phenylpropanoids with antibiotics against bacteria

Journal of Medical Microbiology

Volumn 59, Issue 12, 2010, Pages 1469-1476

  Hemaiswarya, Shanmugam ^a   Doble, Mukesh ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY MADRAS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

2,4,5 TRIMETHOXYCINNAMIC ACID; 3,4 DIMETHOXYCINNAMIC ACID; AMIKACIN; AMPICILLIN; CAFFEIC ACID; CHLOROGENIC ACID; CINNAMIC ACID; CINNAMIC ACID DERIVATIVE; CIPROFLOXACIN; ERYTHROMYCIN; FERULIC ACID; PARA COUMARIC ACID; UNCLASSIFIED DRUG; VANCOMYCIN;

ARTICLE; BACTERIAL MEMBRANE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; DRUG SENSITIVITY; ENTEROBACTER AEROGENES; ESCHERICHIA COLI; MEMBRANE DAMAGE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIA; CELL MEMBRANE; DRUG SYNERGISM; PROPANOLS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 78649405752     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.022426-0     Document Type: Article

References (34)

1. Aresta, M., Acquaviva, M. I., Baruzzi, F., Lo Noce, R. M., Matarante, A., Narracci, M., Stabili, L. & Cavallo, R. A. (2010). Isolation and characterization of polyphenols-degrading bacteria from olive-mill wastewaters polluted soil. World J Microbiol Biotechnol 26, 639-647.
2. Betrosian, A. P. & Douzinas, E. E. (2009). Ampicillin-sulbactam: an update on the use of parenteral and oral forms in bacterial infections. Expert Opin Drug Metab Toxicol 5, 1099-1112.
3. Campos, M. A., Morey, P. & Bengoechea, J. A. (2006). Quinolones sensitize Gram-negative bacteria to antimicrobial peptides. Antimicrob Agents Chemother 50, 2361-2367. (Pubitemid 43993173)
4. Campos, F. M., Couto, J. A., Figueiredo, A. R., Tóth, I. V., Rangel, A. O. S. S. & Hogg, T. A. (2009). Cell membrane damage induced by phenolic acids on wine lactic acid bacteria. Int J Food Microbiol 135, 144-151.
5. Clifford, M. N. (1999). Chlorogenic acids and other cinnamates - nature, occurrence and dietary burden. J Sci Food Agric 79, 362-372.
6. Clifford, M. N. (2000). Chlorogenic acids and other cinnamates - nature, occurrence, dietary burden, absorption and metabolism. J Sci Food Agric 80, 1033-1043.
7. CLSI (2006). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 7th edn. Approved Standard M7-A7. Wayne, PA: Clinical and Laboratory Standards Institute.
8. Couteau, D., McCartney, A. L., Gibson, G. R., Williamson, G. & Faulds, C. B. (2001). Isolation and characterization of human colonic bacteria able to hydrolyse chlorogenic acid. J Appl Microbiol 90, 873-881. (Pubitemid 32500234)
9. Ghose, A. K., Viswanadhan, V. N. & Wendoloski, J. J. (1998). Prediction of hydrophobic (lipophilic) properties of small organic molecules using fragmental methods: an analysis of ALOGP and CLOGP methods. J Phys Chem 102, 3762-3772.
10. Gonthier, M.-P., Verny, M.-A., Besson, C., Rémésy, C. & Scalbert, A. (2003). Chlorogenic acid bioavailability largely depends on its metabolism by the gut microflora in rats. J Nutr 133, 1853-1859. (Pubitemid 36666525)
11. Gonthier, M.-P., Rémésy, C., Scalbert, A., Cheynier, V., Souquet, J.-M., Poutanen, K. & Aura, A.-M. (2006). Microbial metabolism of caffeic acid and its esters chlorogenic and caftaric acids by human faecal microbiota in vitro. Biomed Pharmacother 60, 536-540.
12. Gumbinger, H. G., Vahlensieck, U. & Winterhoff, H. (1993). Metabolism of caffeic acid in the isolated perfused rat liver. Planta Med 59, 491-493. (Pubitemid 24019533)
13. Hemaiswarya, S. & Doble, M. (2009). Synergistic interaction of eugenol with antibiotics against Gram negative bacteria. Phytomedicine 16, 997-1005.
14. Hilliard, J. J., Goldschmidt, R. M., Licata, L., Baum, E. Z. & Bush, K. (1999). Multiple mechanisms of action for inhibitors of histidine protein kinases from bacterial two-component systems. Antimicrob Agents Chemother 43, 1693-1699. (Pubitemid 29331249)
15. Karelson, M. (2000). Molecular Descriptors in QSAR/QSPR. New York: Wiley Interscience.
16. Korkina, L. G. (2007). Phenylpropanoids as naturally occurring antioxidants: from plant defense to human health. Cell Mol Biol (Noisy-le-grand) 53, 15-25.
17. Loke, W. M., Jenner, A. M., Proudfoot, J. M., McKinley, A. J., Hodgson, J. M., Halliwell, B. & Croft, K. D. (2009). A metabolite profiling approach to identify biomarkers of flavonoid intake in humans. J Nutr 139, 2309-2314.
18. Masri, M. S., Robbins, D. J., Emerson, O. H. & DeEds, F. (1964). Selective para- or meta-O-methylation with catechol O-methyl transferase from rat liver. Nature 202, 878-879.
19. Odds, F. C. (2003). Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 52, 1.
20. Olthof, M. R., Hollman, P. C. H. & Katan, M. B. (2001). Chlorogenic acid and caffeic acid are absorbed in humans. J Nutr 131, 66-71.
21. Olthof, M. R., Hollman, P. C., Buijsman, M. N., van Amelsvoort, J. M. & Katan, M. B. (2003). Chlorogenic acid, quercetin-3-rutinoside and black tea phenols are extensively metabolized in humans. J Nutr 133, 1806-1814.
22. Paglia, P., Molinari, G., Pesce, A. & Debbia, E. A. (1989). Dactimicin, a new aminoglycoside: in vitro activity, post-antibiotic effect and interaction with other antibiotics. Eur J Clin Microbiol Infect Dis 8, 639-643. (Pubitemid 19189890)
23. Pai, M. P., Samples, M. L., Mercier, R. C. & Spilde, M. N. (2008). Activity and ultrastructural effects of antifungal combinations against simulated Candida endocardial vegetations. Antimicrob Agents Chemother 52, 2367-2376.
24. Plumb, G. W., Garcia-Conesa, M. T., Kroon, P. A., Rhodes, M., Ridley, S. & Williamson, G. (1999). Metabolism of chlorogenic acid by human plasma, liver, intestine and gut microflora. J Sci Food Agric 79, 390-392. (Pubitemid 29150582)
25. Rastogi, N., Goh, K. S., Wright, E. L. & Barrow, W. W. (1994). Potential drug targets for Mycobacterium avium defined by radiometric drug-inhibitor combination techniques. Antimicrob Agents Chemother 38, 2287-2295. (Pubitemid 24304218)
26. Rastogi, N., Goh, K. S., Horgen, L. & Barrow, W. W. (1998). Synergistic activities of antituberculous drugs with cerulenin and trans-cinnamic acid against Mycobacterium tuberculosis. FEMS Immunol Med Microbiol 21, 149-157. (Pubitemid 28329016)
27. Rozès, N. & Peres, C. (1998). Effects of phenolic compounds on the growth and the fatty acid composition of Lactobacillus plantarum. Appl Microbiol Biotechnol 49, 108-111. (Pubitemid 28055390)
28. Saiman, L. (2007). Clinical utility of synergy testing for multidrug-resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis: 'the motion for'. Paediatr Respir Rev 8, 249-255.
29. Sung, W. S. & Lee, D. G. (2010). Antifungal action of chlorogenic acid against pathogenic fungi, mediated by membrane disruption. Pure Appl Chem 82, 219-226.
30. Tam, V. H., Schilling, A. N. & Nikolaou, M. (2005). Modelling time-kill studies to discern the pharmacodynamics of meropenem. J Antimicrob Chemother 55, 699-706.
31. Todeschini, R. & Consonni, V. (2000). Handbook of Molecular Descriptors. Weinheim: Wiley-VCH.
32. Todeschini, R., Lasagni, M. & Marengo, E. (1994). New molecular descriptors for 2D and 3D structures. Theory. J Chemom 8, 263-272.
33. Tonari, K., Mitsui, K. & Yonemoto, K. (2002). Structure and antibacterial activity of cinnamic acid related compounds. J Oleo Sci 51, 271-273.
34. Wagner, H. & Ulrich-Merzenich, G. (2009). Synergy research: approaching a new generation of phytopharmaceuticals. Phytomedicine 16, 97-110.